The establishment of collagen-induced arthritis (CIA) model in DBA/1 mice, along with the evaluation of relevant indicators, lays a solid foundation for studying the pathogenesis of rheumatoid arthritis. Twelve DBA/1 mice was randomly assigned to either a control or a model group, consisting of six mice per group. Mice within the model group were vaccinated with bovine typeⅡcollagen (CⅡ) to elicit collagen-induced arthritis (CIA). The changes in body weight, paw swelling degree, and arthritis index score were observed and recorded. Hematoxylin-eosin (HE) staining was used to observe the pathological changes of ankle joint. Immunohistochemistry was used to detect the expression of PI3K/AKT/mTOR signaling pathway proteins, S100A4 and VEGF. Compared with the control group, the mice in the model group exhibited a marked reduction in body weight (P<0.05), with apparent paw swelling and a notably elevated arthritis index score (P<0.01). Histological analysis of the ankle joints in the model group showed an increase in synovial tissue, a substantial infiltration of inflammatory cells, pannus formation, degeneration and necrosis of articular cartilage, subchondral bone destruction, as well as a narrowed joint space. Additionally, the abundance of proteins within the PI3K/AKT/mTOR signaling pathway, S100A4 and VEGF in the ankle joint tissue of the model group were significantly upregulated (P<0.01). The method of inducing CIA in DBA/1 mice utilizing bovine CⅡis reliable, boasting a high incidence rate of CIA. The body weight, paw swelling, arthritis index, and ankle joint pathology of the mice can serve as crucial indicators for evaluating the CIA model. The elevated expression of PI3K, AKT, mTOR, S100A4, and VEGF in the synovial membrane of CIA mice indicates that these factors may potentially serve as targets for the treatment of RA.

Xingda Cai, Keyu Zeng, Weijian Zhang, Dingsheng Zha. Establishing method and expression of related proteins of collagen-induced arthritis model in DBA/1 mice. Frontiers in Medical Science Research (2025), Vol. 7, Issue 1: 47-53. https://doi.org/10.25236/FMSR.2025.070107.

[1] Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis[J]. Lancet, 2023, 402(10416): 2019-2033.

[2] Figus FA, Piga M, Azzolin I, et al. Rheumatoid arthritis: Extra-articular manifestations and comorbidities[J]. Autoimmunity reviews, 2021, 20(4): 102776.

[3] Xu RJ, Chen Y, Chen YJ, et al. Prevalence of frailty in patients with rheumatoid arthritis: a systematic review[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 45-52. 

[4] Malemud CJ. The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?[J]. Future medicinal chemistry, 2015, 7(9): 1137-1147.

[5] Cerezo LA, Remáková M, Tomčik M, et al. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis[J]. Rheumatology, 2014, 53(8): 1520-1526.

[6] Ambartsumian N, Klingelhöfer J, Grigorian M. The Multifaceted S100A4 Protein in Cancer and Inflammation[J]. Methods in molecular biology, 2019, 1929: 339-365. 

[7] Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis[J]. The Journal of experimental medicine, 1977, 146(3): 857-868.

[8] Choudhary N, Bhatt LK, Prabhavalkar KS. Experimental animal models for rheumatoid arthritis[J]. Immunopharmacology and immunotoxicology, 2018, 40(3): 193-200.

[9] Zhang Q, Peng W, Wei S, et al. Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats via suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts [J]. Biomedicine & pharmacotherapy, 2019, 118: 109367.

[10] Jang S, Kwon EJ, Lee JJ. Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells[J]. International journal of molecular sciences, 2022, 23(2): 905.

[11] Liu Y, Pan YF, Xue YQ, et al. uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis[J]. Cellular & molecular immunology, 2018, 15(2): 171-181.

[12] Wang DD, Jiang MY, Wang W, et al. Paeoniflorin-6'-O-benzene sulfonate down-regulates CXCR4-Gβγ-PI3K/AKT mediated migration in fibroblast-like synoviocytes of rheumatoid arthritis by inhibiting GRK2 translocation[J]. Biochemical and biophysical research communications, 2020, 526(3): 805-812.

[13] He W, Xu XD, Wu H. The metastasis-associated protein S100A4 may be a new potential therapeutic target for rheumatoid arthritis[J]. Clinical rheumatology, 2016, 35(2): 549-550. 

[14] Wu YY, Li XF, Wu S, et al. Role of the S100 protein family in rheumatoid arthritis[J]. Arthritis research & therapy, 2022, 24(1): 35.  

[15] Zha DS, Wu H, Lin HS, et al. Expression of S100A4 in synovium of patients with rheumatoid arthritis and its effect on angiogenesis of fibroblast-like synoviocytes by secreting VEGF[J]. Chinese journal of pathophysiology, 2017, 33(6): 1119-1124.